Latest filing published 11 Oct 2021 for Calliditas Therapeutics AB, €4,381.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Katayoun Welin-Berger: trading record in brief
Katayoun Welin-Berger discloses dealings in Calliditas Therapeutics AB to Finansinspektionen. We count 5 filings; the first trade dates from 25 February 2021 and the latest from 11 October 2021.
On the market, this insider has only ever bought: 5 purchases, €71k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €4,381. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 11 October 2021, reports an open-market purchase of €4,381 in Calliditas Therapeutics AB. Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Katayoun Welin-Berger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ SEK 89.006.2% of flowAktieISIN SE0010441584FI:csv-4427230c26957031655fCanonical exit: 6 Jan 2022 (T+90)
- 500 shares@ SEK 87.006.0% of flowAktieISIN SE0010441584FI:csv-9e5cb047985e098db6a5Canonical exit: 9 Jan 2022 (T+90)
- 100 shares@ SEK 125.401.7% of flowAktieISIN SE0010441584FI:csv-badbb636f3cc7aa2fa44Canonical exit: 23 Aug 2021 (T+90)
- 4,000 shares@ SEK 124.7069.2% of flowAktieISIN SE0010441584FI:csv-6c582df0466b854f0027Canonical exit: 23 Aug 2021 (T+90)
- 1,000 shares@ SEK 121.00100.0% of flowAktieISIN SE0010441584FI:A001Q871-1Canonical exit: 26 May 2021 (T+90)
5 of 5 declarations